Skip to main content
SpringerLink
Log in

The impact of polyene, azole, and DNA analogue antimycotics on the cell surface hydrophobicity of Candida albicans and Candida tropicalis in HIV infection

  • Published:
Mycopathologia Aims and scope Submit manuscript

Abstract

Oral candidiasis is the most common opportunistic infection in individuals infected with the human immunodeficiency virus. Though Candida albicans is the major aetiological agent, non-albicans species such Candida tropicalis are now emerging as important agents of such infection. The Candida cell surface hydrophobicity (CSH) is considered a critical factor contributing to its colonization potential and virulence. It is also known that brief exposure to sub-cidal concentrations of antifungal agents is a likely scenario in the oral environment where the administered drugs are diluted continuously due to the flushing action of saliva. Hence the objective of the present study was to compare the CSH of 10 isolates each of C. albicans and C. tropicalis from HIV-infected individuals following brief exposure (1hour) of isolates to sub-therapeutic concentrations of nystatin, amphotericin B, ketoconazole, fluconazole and 5-flurocytosine. The CSH was assessed by a previously described biphasic aqueous-hydrocarbon assay. The mean percentage reduction of CSH of C. albicans following brief exposure to nystatin, amphotericin B, ketoconazole, fluconazole and 5-flurocytosine was27.33 (p < 0.001), 21.34 (p < 0.05), 11.74 (p > 0.05), 18.4 (p > 0.05) and 14.64 (p > 0.05) respectively. The mean percentage reduction of CSH of C. tropicalis following brief exposure to nystatin, amphotericin B, ketoconazole, fluconazole and 5-flurocytosine was 33.81 (p < 0.01), 28.88 (p < 0.01), 12.6 (p > 0.05), 21.53(p > 0.05) and 17.68 (p > 0.05) respectively. A significant inter-species variation in CSH was observed for nystatin and amphoterecin B. Overall the results reveal that the CSH of C. albicans is affected to a significantly lesser degree compared with C. tropicalis when exposed to the antifungals. These data further illustrate another mode of action of antifungals on Candida leading to a reduction in the CSH and thereby the yeast adherence to host tissues.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Powderly WG, Gallant JE, Ghannoum MA, Mayer KH, Navarro EE, Perfect JR. Propharyngeal candidiasis in patients with HIV: suggested guidelines for therapy. AIDS Res Hum Retroviruses 1999; 15: 1619–1623.

    Article  PubMed  CAS  Google Scholar 

  2. Arendorf TM, Bredekamp B, Cloete CA, Sauer G. Oral manifestations of HIV infection in 600 South African patients. J Oral Pathol Med 1998; 27: 176–179.

    Article  PubMed  CAS  Google Scholar 

  3. Cartledge JD, Midgley J, Gazzard BG. Non-albicans oral candidosis in HIV-positive patients. J Antimicrob Chemother 1999; 43: 419–422.

    Article  PubMed  CAS  Google Scholar 

  4. Pfaller M, Wenzel R. Impact of the changing epidemiology of fungal infections in the 1990s. Eur J Clin Microbiol Infect Dis 1992; 11: 287–291.

    Article  PubMed  CAS  Google Scholar 

  5. Tumbarello M, Tacconelli E, de Gaetano Donati K, Morace G, Fadda G, Cauda R. Candidemia in HIV-infected subjects. Eur J Clin Microbiol Infect Dis 1999; 18: 478–483.

    Article  PubMed  CAS  Google Scholar 

  6. Fukazawa Y, Kagaya K. Molecular bases of adhesion of Candida albicans. J Med Vet Mycol 1997; 35: 87–99.

    PubMed  CAS  Google Scholar 

  7. Hazen BW, Hazen KC. Dynamic expression of cell surface hydrophobicity during initial yeast cell growth and before germ tube formation of Candida albicans. Infect Immun 1988; 56: 2521–2525.

    PubMed  CAS  Google Scholar 

  8. Hazen KC, Brawner DL, Riesselman MH, Jutila MA, Cutler JE. Differential adherence of hydrophobic and hydrophilic Candida albicans yeast cells to mouse tissues. Infect Immun 1991; 59: 907–912.

    PubMed  CAS  Google Scholar 

  9. Samaranayake LP, MacFarlane TW. Oral Candidosis. London: Wright; 1990.

    Google Scholar 

  10. White TC, Marr KA, Bowden RA. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 1998; 11: 382–402.

    PubMed  CAS  Google Scholar 

  11. Minagi S, Miyake Y, Inagaki K, Tsuru H, Suginaka H. Hydrophobic interaction in Candida albicans and Candida tropicalis adherence to various denture base resin materials. Infect Immun 1985; 47: 11–14.

    PubMed  CAS  Google Scholar 

  12. Ellepola AN, Samaranayake LP. The effect of limited exposure to antimycotics on the relative cell-surface hydrophobicity and the adhesion of oral Candida albicans to buccal epithelial cells. Arch Oral Biol 1998; 43: 879–887.

    Article  PubMed  CAS  Google Scholar 

  13. Hazen KC, Mandell G, Coleman E, Wu G. Influence of fluconazole at subinhibitory concentrations on cell surface hydrophobicity and phagocytosis of Candida albicans. FEMS Microbiol Lett 2000; 183: 89–94.

    Article  PubMed  CAS  Google Scholar 

  14. Samaranayake LP, MacFarlane TW, Lamey PJ, Ferguson MM. A comparison of oral rinse and imprint sampling techniques for the detection of yeast, coliform and Staphylococcus aureus carriage in the oral cavity. J Oral Pathol 1986; 15: 386–388.

    Article  PubMed  CAS  Google Scholar 

  15. Buesching WJ, Kurek K, Roberts GD. Evaluation of the modified API 20C system for identification of clinically important yeasts. J Clin Microbiol 1979; 9: 565–569.

    PubMed  CAS  Google Scholar 

  16. National Committee for Clinical Laboratory Standards (NCCL), 1997. In Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard. NCCLS document M27-A. Wayne, Pa.

  17. Warnock DW, Johnson EM, Rogers TR. Multi-centre evaluation of the E test method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy. J Antimicrob Chemother 1998; 42: 321–331.

    Article  PubMed  CAS  Google Scholar 

  18. McDonald PJ, Craig WA, Kunin CM. Persistent effect of antibiotics on Staphylococcus aureus after exposure for limited periods of time. J Infect Dis 1977; 135: 217–223.

    PubMed  CAS  Google Scholar 

  19. Sweet SP, MacFarlane TW, Samaranayake LP. Determination of cell surface hydrophobicity of oral bacteria using a modified hydrocarbon adherence method. FEMS Microbiol Lett 1987; 48: 159–163.

    Article  CAS  Google Scholar 

  20. Anil S, Challacombe SJ. Oral lesions of HIV and AIDS in Asia: an overview. Oral Dis 1997; 3 Suppl 1: S36–40.

    PubMed  Google Scholar 

  21. Samaranayake LP, Holmstrup P. Oral candidiasis and human immunodeficiency virus infection. J Oral Pathol Med 1989; 18: 554–564.

    Article  PubMed  CAS  Google Scholar 

  22. Egusa H, Ellepola AN, Nikawa H, Hamada T, Samaranayake LP. Exposure to subtherapeutic concentrations of polyene antifungals suppresses the adherence of Candida species to denture acrylic. Chemotherapy 2000; 46: 267–274.

    Article  PubMed  CAS  Google Scholar 

  23. Hazen KC, Hazen BW. Hydrophobic surface protein masking by the opportunistic fungal pathogen Candida albicans. Infect Immun 1992; 60: 1499–1508.

    PubMed  CAS  Google Scholar 

  24. Egusa H, Ellepola AN, Nikawa H, Hamada T, Samaranayake LP. Sub-therapeutic exposure to polyene antimycotics elicits a post-antifungal effect (PAFE) and depresses the cell surface hydrophobicity of oral Candida albicans isolates. J Oral Pathol Med 2000; 29: 206–213.

    Article  PubMed  CAS  Google Scholar 

  25. Ellepola AN, Samaranayake LP. The in vitro post-antifungal effect of nystatin on Candida species of oral origin. J Oral Pathol Med 1999; 28: 112–116.

    Article  PubMed  CAS  Google Scholar 

  26. Ellepola AN, Panagoda GJ, Samaranayake LP. Adhesion of oral Candida species to human buccal epithelial cells following brief exposure to nystatin. Oral Microbiol Immunol 1999; 14: 358–363.

    Article  PubMed  CAS  Google Scholar 

  27. Scully C, el-Kabir M, Samaranayake LP. Candida and oral candidosis: a review. Crit Rev Oral Biol Med 1994; 5: 125–157.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Oral Biosciences, Faculty of Dentistry, University of Hong Kong, Hong Kong

    S. Anil, A. N. B. Ellepola & L. P. Samaranayake

  2. Faculty of Dentistry, University of Kerala, India

    S. Anil

  3. Faculty of Dental Sciences, University of Peradeniya, Sri Lanka

    A. N. B. Ellepola

Authors
  1. S. Anil
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. N. B. Ellepola
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. P. Samaranayake
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Anil, S., Ellepola, A.N.B. & Samaranayake, L.P. The impact of polyene, azole, and DNA analogue antimycotics on the cell surface hydrophobicity of Candida albicans and Candida tropicalis in HIV infection. Mycopathologia 153, 179–185 (2002). https://doi.org/10.1023/A:1014932302518

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1014932302518

Search

Navigation